BioSpace News Archive

Business

ViewRay Reports Fourth Quarter and Full Year 2018 Results

ViewRay, Inc. announced financial results for the fourth quarter and full year ended December 31, 2018.

March 14, 2019
·
8 min read
Policy

Neovasc Completes Successful Quality System Surveillance Audit

Neovasc Inc. announced that it has successfully completed its 2019 mandatory Surveillance Audit with its Notified Body, resulting in the maintenance of the Regulatory Certification and maintenance of the ISO 13485: 2016 certification of the quality management system.

March 14, 2019
·
8 min read
Business

BioLife Solutions Announces Fourth Quarter and Full Year 2018 Financial Results

BioLife Solutions, Inc. reported financial results and operational highlights for the fourth quarter and full year ended December 31, 2018.

March 14, 2019
·
11 min read
Genetown

Organogenesis Holdings Inc. Announces New $100 Million Credit Agreement with Silicon Valley Bank and MidCap Financial

Organogenesis Holdings Inc. announced a new credit agreement with Silicon Valley Bank, the lead agent, and MidCap Financial.

March 14, 2019
·
4 min read
Business

BioPharmX Reports Fourth Quarter and Full Year 2019 Financial Results

BioPharmX Corporation, a specialty pharmaceutical company focused on developing innovative medical dermatology products, reports financial results for the quarter and year ended January 31, 2019.

March 14, 2019
·
11 min read
Deals

Achieve Reports Financial Results for Year-End 2018 and Provides Cytisinicline Clinical Development Update

Achieve Life Sciences, Inc. provided an update on the cytisinicline clinical development program and announced fourth quarter and year-end 2018 financial results.

March 14, 2019
·
8 min read
Business

PDL BioPharma Reports 2018 Fourth Quarter and Full Year Financial Results

PDL BioPharma, Inc. reports financial results for the three and 12 months ended December 31, 2018

March 14, 2019
·
15 min read
Business

Deciphera Pharmaceuticals, Inc. Announces Fourth Quarter and Year-end 2018 Financial Results

Enrollment Completed in INVICTUS Pivotal Phase 3 Clinical Study in Fourth-line and Fourth-line Plus GIST; Top-line Data Expected in Mid-2019

March 14, 2019
·
13 min read
Business

Tetraphase Pharmaceuticals Reports Fourth Quarter and Full-Year 2018 Financial Results and Highlights Achievements and Key 2019 Milestones

Tetraphase Pharmaceuticals, Inc reported financial results for the fourth quarter and year ended December 31, 2018, provided an overview of recent achievements, and highlighted key milestones for 2019.

March 14, 2019
·
14 min read
Business

Harpoon Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update

Lead Tri-specific T cell Activating Construct (TriTAC) candidate, HPN424, continues to advance in a Phase 1 clinical trial for the treatment of prostate cancer

March 14, 2019
·
12 min read